Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia
about
Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remissionNK cell-based immunotherapies in Pediatric Oncology.Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.Development of treatment and clinical results in childhood acute myeloid leukemia in Poland.Elevated levels of CXCL10 in the Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) during and between febrile episodes; an indication of a persistent activation of the innate immune system.
P2860
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Soluble interleukin-2 receptor ...... diatric acute myeloid leukemia
@ast
Soluble interleukin-2 receptor ...... diatric acute myeloid leukemia
@en
type
label
Soluble interleukin-2 receptor ...... diatric acute myeloid leukemia
@ast
Soluble interleukin-2 receptor ...... diatric acute myeloid leukemia
@en
prefLabel
Soluble interleukin-2 receptor ...... diatric acute myeloid leukemia
@ast
Soluble interleukin-2 receptor ...... diatric acute myeloid leukemia
@en
P2093
P2860
P356
P1476
Soluble interleukin-2 receptor ...... diatric acute myeloid leukemia
@en
P2093
Beverly J Lange
Eric L Sievers
Jaquelyn A Hank
Paul M Sondel
Robert B Gerbing
Todd A Alonzo
P2860
P304
P356
10.1002/PBC.22966
P577
2011-06-16T00:00:00Z